tetano
Editor, Senior Moderator
World J Gastroenterol
. 2022 Feb 14;28(6):683-688.
doi: 10.3748/wjg.v28.i6.683.
COVID-19, liver dysfunction and pathophysiology: A conceptual discussion
Jucier Gonçalves Júnior[SUP] 1 [/SUP]
Affiliations
Abstract
The intra and extracellular pathways of hepatic injury by coronavirus disease 2019 (COVID-19) are still being studied. Understanding them is important to treat this viral disease and other liver and biliary tract disorders. Thus, this paper aims to present three hypotheses about liver injury caused by COVID-19: (1) The interactions between severe acute respiratory syndrome coronavirus 2 spike protein and membrane receptors in the hepatocyte; (2) The dysbiosis and "gut-liver axis" disruption in patients with serious clinical presentations of COVID-19; and (3) The inflammatory response exacerbated through the production of interleukins such as interleukin-6. However, despite these new perspectives, the pathophysiological process of liver injury caused by COVID-19 is still complex and multifactorial. Thus, understanding all these variables is a challenge to science but also the key to propose individualized and effective patient therapies.
Keywords: COVID-19; Immunopathology; Intracellular signaling peptides and proteins; Liver diseases; Liver injury; SARS-CoV-2.
. 2022 Feb 14;28(6):683-688.
doi: 10.3748/wjg.v28.i6.683.
COVID-19, liver dysfunction and pathophysiology: A conceptual discussion
Jucier Gonçalves Júnior[SUP] 1 [/SUP]
Affiliations
- PMID: 35317425
- PMCID: PMC8900549
- DOI: 10.3748/wjg.v28.i6.683
Abstract
The intra and extracellular pathways of hepatic injury by coronavirus disease 2019 (COVID-19) are still being studied. Understanding them is important to treat this viral disease and other liver and biliary tract disorders. Thus, this paper aims to present three hypotheses about liver injury caused by COVID-19: (1) The interactions between severe acute respiratory syndrome coronavirus 2 spike protein and membrane receptors in the hepatocyte; (2) The dysbiosis and "gut-liver axis" disruption in patients with serious clinical presentations of COVID-19; and (3) The inflammatory response exacerbated through the production of interleukins such as interleukin-6. However, despite these new perspectives, the pathophysiological process of liver injury caused by COVID-19 is still complex and multifactorial. Thus, understanding all these variables is a challenge to science but also the key to propose individualized and effective patient therapies.
Keywords: COVID-19; Immunopathology; Intracellular signaling peptides and proteins; Liver diseases; Liver injury; SARS-CoV-2.